Statistics
Publications
19
Citations
1.5K
H-Index
16
Active since
1992
Takumi Kawabe is an author at Dana-Farber Cancer Institute specializing in life sciences, oncology, and cell-cycle checkpoints.
Publications per year
1992–2021
19
19
G2 checkpoint abrogators as anticancer drugs
Takumi Kawabe · Molecular Cancer Therapeutics · 2004 · 383 citations · Full text
Tomoaki Ando, Takumi Kawabe, Hirotaka Ohara et al. · Journal of Biological Chemistry · 2001 · 200 citations · Full text
Takashi Okamoto, H. Ogiwara, Takuma Hayashi et al. · International Immunology · 1992 · 140 citations
CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
Keiichi Sakakibara, Naoya Saito, Takuji Sato et al. · Blood · 2011 · 118 citations
1–5 of 19